Viewing Study NCT03913520


Ignite Creation Date: 2025-12-25 @ 4:26 AM
Ignite Modification Date: 2026-02-28 @ 2:28 PM
Study NCT ID: NCT03913520
Status: COMPLETED
Last Update Posted: 2020-10-22
First Post: 2019-04-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Outcome of Patients With Congenital Heart Disease
Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Organization:

Study Overview

Official Title: Postoperative Outcome of Patients With Congenital Heart Disease Presenting for Non-cardiac Interventions
Status: COMPLETED
Status Verified Date: 2020-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: OUTCARDIOP
Brief Summary: Advanced surgical and medical healthcare systems have resulted in an increased prevalence of children and adults with congenital heart disease in Western countries. These patients often necessitate non-cardiac interventions. Previous studies have demonstrated that these patients are at increased risk of morbidity and mortality when presenting for non-cardiac interventions. The aim of this study is to know the prevalence of patients with congenital heart disease presenting for non-cardiac interventions in a tertiary hospital and to determine their outcome.
Detailed Description: Previous studies have shown that children and adults presenting with congenital heart disease are at increased risk of morbidity and mortality after non-cardiac interventions. This risk depends on the type of pathology, the age of the patient and the experience of the physicians in charge of these patients.

We sought to determine the prevalence of children and adults with congenital heart disease presenting for non-cardiac interventions and to investigate their outcome.

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: